NuScriptRX has raised $8m of funding from a range of venture capital firms, several of which operate under the local TNInvestco program.
US-based institutional pharmacy NuScriptRX closed an $8m round of series C financing, and secured a $5m line of credit with Square 1 Bank, on Monday.
The series C round was led by private equity firm Council Capital, with participation from venture capital (VC) firms Clayton Associates, Envest, Council & Enhanced Tennessee Fund, Nest-TN, Tennessee Angel Fund and Innova, as well as a further unnamed strategic investor.
The latter four firms are all part of the Tennessee General Assembly’s $200m…